Raj Chovatiya, MD, PhD: Safety of Oral JAK Inhibitors for Atopic Dermatitis

Dr. Chovatiya discusses safety data on upadacitinib and abrocitinib for the treatment of atopic dermatitis.

MORE CONFERENCE COVERAGE

Julie Harper, MD: Rosacea Update

Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in...

PLAY